Lipocine (LPCN) Return on Sales (2018 - 2025)
Lipocine's (LPCN) quarterly Return on Sales came in at 0.28% in Q3 2025, down 28.0% YoY from 0.39% in Q3 2024, and down 685.43% on a QoQ basis from 0.04% in Q2 2025.
Lipocine (LPCN) Return on Sales (2018 - 2025) Analysis & Trends
Lipocine (LPCN) has 8 years of Return on Sales data on file, last reported at 0.28% in Q3 2025.
- Quarterly Return on Sales fell 28.0% year-over-year to 0.28% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.01% (down 1.0% YoY) and the FY2024 annual result came in at 0.0%, up 5.0% from the prior year.
- Return on Sales slipped to 0.28% in Q3 2025, from 0.04% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2021 to a low of 1.78% in Q2 2023.
- A 5-year average of 0.25% and a median of 0.05% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales plunged 173 bps — and 2024, when it soared 144 bps.
- Tracing LPCN's Return on Sales over 5 years: stood at 0.01% in 2021, then plunged by 2243 bps to 0.17% in 2022, then soared by 69 bps to 0.05% in 2023, then surged by 110 bps to 0.01% in 2024, then plunged by 5553 bps to 0.28% in 2025.
- The last three Return on Sales figures came in at 0.28% (Q3 2025), 0.04% (Q2 2025), and 0.2% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 0.00% |
| 10 | Lipocine | 11.37 Mn | -12.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.28% |
| Jun 30, 2025 | -0.04% |
| Mar 31, 2025 | -0.20% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.34% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -1.78% |
| Mar 31, 2023 | -0.70% |
| Dec 31, 2022 | -0.17% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.05% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | -0.56% |
| Dec 31, 2020 | -1.00% |
| Sep 30, 2020 | -1.03% |
| Dec 31, 2019 | -0.62% |